June 9 (Reuters) - Laboratory Corporation of America
Holdings LH.N :
* LABCORP ANNOUNCES INFORMATION IN CONNECTION WITH ITS
SPIN-OFF OF
FORTREA
* LABCORP - FORTREA WILL HOLD LABCORP'S CLINICAL DEVELOPMENT
AND
COMMERCIALIZATION SERVICES BUSINESS
* LABCORP- SPIN-OFF IS EXPECTED TO BE EFFECTED THROUGH
DISTRIBUTION OF 100 PERCENT OF COMMON STOCK OF FORTREA TO
HOLDERS OF LABCORP'S COMMON STOCK
* LABCORP- U.S. SEC DECLARED FORTREA'S REGISTRATION
STATEMENT ON
FORM 10 EFFECTIVE TODAY
* LABCORP - NASDAQ APPROVED LISTING OF FORTREA'S COMMON
STOCK ON
NASDAQ STOCK MARKET UNDER SYMBOL "FTRE"
Source text for Eikon: ID:nPnbrb2GRa
Further company coverage: LH.N
((Reuters.Briefs@thomsonreuters.com;))